David Metheny
Psychiatric/Mental Health · Albany, GANPI 1538391453
Payments from drug & device makers
Across 192 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$828
- Teva Pharmaceuticals USA, Inc.$461
- Otsuka America Pharmaceutical, Inc.$415
- Neurocrine Biosciences, Inc.$407
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$241
- E.r. Squibb & Sons, L.L.C.$225
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,60097%
- Education$1133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $828 |
| Teva Pharmaceuticals USA, Inc. | 22 | $461 |
| Otsuka America Pharmaceutical, Inc. | 21 | $415 |
| Neurocrine Biosciences, Inc. | 18 | $407 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $241 |
| E.r. Squibb & Sons, L.L.C. | 6 | $225 |
| Alkermes, Inc. | 11 | $199 |
| Johnson & Johnson | 9 | $176 |
| Vanda Pharmaceuticals Inc. | 7 | $138 |
| GSK | 9 | $123 |
| Axsome Therapeutics, Inc. | 6 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $106 |
| Lundbeck LLC | 4 | $69 |
| Indivior Inc. | 1 | $29 |
| Braeburn Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $20 |
| Masimo Corporation | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,713 in reported general payments places this provider in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 77 | $206,771 |
| IngrezzaValbenazine Tosylate | 17 | $139,153 |
| RexultiBrexpiprazole | 65 | $92,829 |
| VraylarCariprazine Hcl | 50 | $71,322 |
| Abilify MaintenaAripiprazole | 11 | $26,139 |
| TrintellixVortioxetine Hydrobromide | 41 | $20,380 |
| Aripiprazole | 183 | $11,979 |
| Chlorpromazine Hcl | 37 | $11,189 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 11 | $9,028 |
| Buspirone Hcl | 323 | $5,328 |
| Quetiapine Fumarate | 280 | $4,269 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 103 | $3,999 |
| Hydroxyzine Hcl | 178 | $3,319 |
| Sertraline Hcl | 326 | $2,975 |
| Trazodone Hcl | 351 | $2,819 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $176 | $206,77177 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $407 | $139,15317 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $415 | $118,96776 claims |
| AbbVieVraylar | $828 | $71,32250 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $106 | $20,38041 claims |
| Almatica Pharma LLCSertraline Hcl | $20 | $2,975326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Albany
- Taylor LeblancAlbany$48K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.